glp-1 and parkinson's disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes obesity, including cardiovascular and neurodegenerative disorders GLP-1 drug may help with

Conditions that do not qualify under the Bridge (commonly asked) The following do not qualify under any Bridge tier, even when paired with the right BMI: Type 2 diabetes alone

Tirzepatide's SURMOUNT-5 head-to-head vs semaglutide (2025): Zepbound demonstrated 47% greater relative weight loss vs Wegovy in a direct Phase 3b comparison the most commercially significant clinical trial result in the obesity market, directly challenging Novo Nordisk's market leadership

We encourage anyone considering medical weight loss to engage in open dialogue with their healthcare team

The importance of lab testing Lab testing plays an important role in guiding your B12 treatments

Frequently Asked Questions About the Remedy Meds GLP-1 Program What GLP-1 medications does Remedy Meds offer

The information presented in this activity is not meant to serve as a guideline for patient management